首页> 美国卫生研究院文献>Scientific Reports >Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton He and C beams measured with CR-39 plastic nuclear track detectors
【2h】

Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton He and C beams measured with CR-39 plastic nuclear track detectors

机译:使用CR-39塑料核径迹检测器测量的治疗性质子He和C束中次级靶标碎片对健康组织中剂量的贡献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET∞H2O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were measured using CR-39 plastic nuclear track detectors and analyzed by means of atomic force microscopy. It was found that secondary target fragments contributed 20% to dose equivalent for primary protons (157 MeV), 13% for primary helium ions (145 MeV) and 4% for primary carbon ions (383 MeV), respectively. Little research has been done on the contribution from these particles to primary given dose. The smaller contribution measured for energetic carbon ion beams compared to proton beams can be considered an advantage of carbon ion radiotherapy over proton radiotherapy.
机译:质子和重离子在组织中一次粒子诱导的核靶片段化反应中,布拉格能谱平台内沉积的LET∞H2O≥15keV /μm二次粒子的线性能量转移谱,吸收剂量和等效剂量使用CR-39塑料核径迹探测器对放射疗法进行了测量,并通过原子力显微镜进行了分析。结果发现,次要靶片段的等效剂量分别为初级质子(157 MeV / n)的20%,初级氦离子(145 MeV / n)的13%和初级碳离子(383 MeV / n)的4%。关于这些颗粒对初次给定剂量的贡献的研究很少。与质子束相比,对于高能碳离子束测得的贡献较小,可以认为是碳离子放射治疗优于质子放射治疗的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号